RELAFEN 750
Generic Name: nabumetone
Pill imprint RELAFEN 750 has been identified as Relafen 750 mg.
Relafen is used in the treatment of rheumatoid arthritis; osteoarthritis; back pain; muscle pain; sciatica (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy.
Relafen 750 mg is not subject to the Controlled Substances Act.
See also related documents.
Relafen Images
- Generic Name:
- nabumetone
- Imprint:
-
RELAFEN
750 - Strength:
- 750 mg
- Color:
- Beige
- Size:
- 19.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- hypromellose
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium lauryl sulfate
sodium starch glycolate
titanium dioxide
ferric oxide
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00029-4852


